Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P48
Within normal range
vs 3Y Ago
-0.5x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -20.65% |
| Q3 2025 | 153.79% |
| Q2 2025 | -43.06% |
| Q1 2025 | 22.06% |
| Q4 2024 | -205.06% |
| Q3 2024 | 42.15% |
| Q2 2024 | 59.32% |
| Q1 2024 | 3.49% |
| Q4 2023 | -7.07% |
| Q3 2023 | -49.26% |
| Q2 2023 | -10.32% |
| Q1 2023 | -102.80% |
| Q4 2022 | 41.19% |
| Q3 2022 | -327.00% |
| Q2 2022 | 71.64% |
| Q1 2022 | -24.62% |
| Q4 2021 | -277.30% |
| Q3 2021 | -65.96% |
| Q2 2021 | 271.57% |
| Q1 2021 | -20.13% |
| Q4 2020 | -48.55% |
| Q3 2020 | -131.92% |
| Q2 2020 | -42.32% |
| Q1 2020 | -144.82% |
| Q4 2019 | -44.10% |
| Q3 2019 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |